Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-24

Clinical Trial Update: Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial updating the co-administration of olmesartan medoxomil with amlodipine in patients with hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Hypertension | Phase 3 | Status: COMPLETED